A confirmatory seamless phase II/III clinical trial design incorporating short-term endpoint information.
about
Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome data.Optimizing the data combination rule for seamless phase II/III clinical trials.Adaptive clinical trial designs in oncology.Correcting for bias in the selection and validation of informative diagnostic tests.Advances in Statistical Approaches Oncology Drug Development.Sample Size Reassessment and Hypothesis Testing in Adaptive Survival TrialsDesigning multi-arm multi-stage clinical trials using a risk-benefit criterion for treatment selection.Controlled multi-arm platform design using predictive probability.Flexible selection of a single treatment incorporating short-term endpoint information in a phase II/III clinical trial.Adaptive Clinical Trials: Overview of Early-Phase Designs and Challenges.Maximum inflation of the type 1 error rate when sample size and allocation rate are adapted in a pre-planned interim look.Blinded versus unblinded estimation of a correlation coefficient to inform interim design adaptations.A comparison of methods for treatment selection in seamless phase II/III clinical trials incorporating information on short-term endpoints.A multi-stage drop-the-losers design for multi-arm clinical trials.An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information.
P2860
Q30813133-4C12F7A9-B240-46DD-A118-739DE0B85A74Q30860286-61F31505-E709-481B-BC99-4A29B77C3225Q35206844-E5883369-67D5-4D67-9BB3-E27562AB6227Q35556604-E1204D53-7058-4C58-9D3A-7983A495A16CQ35565672-51D88451-4ED3-4D6D-966C-669D9F5A55BFQ35919624-E4819B5A-D055-42F8-8A9B-374905FEFF2AQ37106434-31A0C6C7-6120-4D7D-8F73-D669E35BFB5EQ37289826-4747643B-AF1F-4A8D-A179-22A009D9813FQ38280824-58DB9454-037C-4517-8765-0222C028D627Q38697445-DF21C06E-7FE4-44F8-99ED-A48F7DE2ECB7Q40344979-D280A1F1-8754-4053-BA0C-2AC51B2035C1Q41883714-A9682DCA-3A56-44E4-B809-374C6CB3E78EQ42130183-28819650-032F-4199-8EC8-F326CE7EE9D5Q42322419-32723D1F-C621-494E-BC75-180800C5CC37Q46743339-A28A38E3-F725-4C22-9FFE-F2E1811D645F
P2860
A confirmatory seamless phase II/III clinical trial design incorporating short-term endpoint information.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
A confirmatory seamless phase ...... ort-term endpoint information.
@en
A confirmatory seamless phase ...... ort-term endpoint information.
@nl
type
label
A confirmatory seamless phase ...... ort-term endpoint information.
@en
A confirmatory seamless phase ...... ort-term endpoint information.
@nl
prefLabel
A confirmatory seamless phase ...... ort-term endpoint information.
@en
A confirmatory seamless phase ...... ort-term endpoint information.
@nl
P356
P1476
A confirmatory seamless phase ...... ort-term endpoint information.
@en
P304
P356
10.1002/SIM.3863
P407
P577
2010-02-26T00:00:00Z